RESEARCH TRIANGLE PARK, N.C., Mar 10, 2010 (BUSINESS WIRE) -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced
that Lawrence D. Stern, Chairman and Chief Executive Officer of
Talecris, will present at the Goldman Sachs Leveraged Finance Healthcare
Conference at 8:15 a.m., Wednesday, Mar. 17 at the Goldman Sachs
Conference Center in New York.
A live webcast of Talecris' presentation will be accessible through the
investor relations section of the Talecris Web site, www.talecris.com/investor-relations.htm.
A replay of the webcast will be available for 30 days following the
presentation and can be accessed at the same Web address.
About Talecris Biotherapeutics: Inspiration. Dedication.
Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology
company that discovers, develops and produces critical care treatments
for people with life-threatening disorders in a variety of therapeutic
areas including immunology, pulmonology, neurology and hemostasis. For
more information, please visit: www.talecris.com.
SOURCE: Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp.
Investor Relations:
Drayton Virkler, 919-316-2356
drayton.virkler@talecris.com
or
Corporate Communications:
Becky Levine, 919-316-6590
becky.levine@talecris.com
